Clinical Study

Replanning Criteria and Timing Definition for Parotid Protection-Based Adaptive Radiation Therapy in Nasopharyngeal Carcinoma

Table 1

Patient characteristics.

CharacteristicsNumber of patientsPercent (%)

Gender
 Male4080
 Female1020
Age11–80 years (median, 44 years)
UICC stage (2002)
 T
  11326
  21632
  31326
  4816
 N
  01836
  11530
  21530
  324
 M
  050100
Treatment method
 RT2040
 CCRT1326
 ICT + CCRT1734
Primary tumor volume 37.54 25.23 (4.36–118.00) cm3
Volume of metastatic nodes 13.15 23.18 (0–133.35) cm3
Weight loss rate at the end of RT10.80 4.12%

RT: radiation therapy; CCRT: concurrent chemoradiotherapy; ICT: induced chemotherapy.